Use of Bacteriophages to Control Escherichia coli O157:H7 in Domestic Ruminants, Meat Products, and Fruits and Vegetables

被引:35
作者
Wang, Lili [1 ,2 ]
Qu, Kunli [1 ]
Li, Xiaoyu [1 ,2 ]
Cao, Zhenhui [3 ]
Wang, Xitao [1 ,4 ]
Li, Zhen [1 ]
Song, Yaxiong [1 ]
Xu, Yongping [1 ,2 ]
机构
[1] Dalian Univ Technol, Sch Life Sci & Biotechnol, 2 Linggong Rd, Dalian 116024, Peoples R China
[2] Minist Educ, Ctr Food Safety Anim Origin, Dalian, Peoples R China
[3] Yunnan Agr Univ, Fac Anim Sci & Technol, Kunming, Yunnan, Peoples R China
[4] Dalian SEM Bioengn Technol Co, Dept Res & Dev, Dalian, Peoples R China
关键词
bacteriophage; E. coli O157:H7; phage therapy; ruminants; food; FEEDLOT CATTLE; PHAGE COCKTAIL; O157-H7; LEVELS; GROUND-BEEF; THERAPY; OUTBREAK; O157/H7; ANTIBIOTICS; BOVINE; CONTAMINATION;
D O I
10.1089/fpd.2016.2266
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Escherichia coli O157:H7 is an important foodborne pathogen that causes severe bloody diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome. Ruminant manure is a primary source of E. coli O157:H7 contaminating the environment and food sources. Therefore, effective interventions targeted at reducing the prevalence of fecal excretion of E. coli O157:H7 by cattle and sheep and the elimination of E. coli O157:H7 contamination of meat products as well as fruits and vegetables are required. Bacteriophages offer the prospect of sustainable alternative approaches against bacterial pathogens with the flexibility of being applied therapeutically or for biological control purposes. This article reviews the use of phages administered orally or rectally to ruminants and by spraying or immersion of fruits and vegetables as an antimicrobial strategy for controlling E. coli O157:H7. The few reports available demonstrate the potential of phage therapy to reduce E. coli O157:H7 carriage in cattle and sheep, and preparation of commercial phage products was recently launched into commercial markets. However, a better ecological understanding of the phage E. coli O157:H7 will improve antimicrobial effectiveness of phages for elimination of E. coli O157:H7 in vivo.
引用
收藏
页码:483 / 493
页数:11
相关论文
共 80 条
  • [31] Use of a bacteriophage to inactivate Escherichia coli O157:H7 on beef
    Hudson, J. A.
    Billington, C.
    Cornelius, A. J.
    Wilson, T.
    On, S. L. W.
    Premaratne, A.
    King, N. J.
    [J]. FOOD MICROBIOLOGY, 2013, 36 (01) : 14 - 21
  • [32] Alternatives to antibiotics: Utilization of bacterlophage to treat colibacillosis and prevent foodborne pathogens
    Huff, WE
    Huff, GR
    Rath, NC
    Balog, JM
    Donoghue, AM
    [J]. POULTRY SCIENCE, 2005, 84 (04) : 655 - 659
  • [33] Intralytix, INTR REC FDA REG CLE
  • [34] Isolation and Host Range of Bacteriophage with Lytic Activity against Methicillin-Resistant Staphylococcus aureus and Potential Use as a Fomite Decontaminant
    Jensen, Kyle C.
    Hair, Bryan B.
    Wienclaw, Trevor M.
    Murdock, Mark H.
    Hatch, Jacob B.
    Trent, Aaron T.
    White, Tyler D.
    Haskell, Kyler J.
    Berges, Bradford K.
    [J]. PLOS ONE, 2015, 10 (07):
  • [35] Johnson R. P., 2008, Animal Health Research Reviews, V9, P201, DOI 10.1017/S1466252308001576
  • [36] Kamel M, 2015, TROP ANIM HLTH PROD, V47, P1
  • [37] Enterohaemorrhagic Escherichia coli in human medicine
    Karch, H
    Tarr, PI
    Blelaszewska, M
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 295 (6-7) : 405 - 418
  • [38] Expansion of Shiga Toxin-Producing Escherichia coli by Use of Bovine Antibiotic Growth Promoters
    Kim, Jong-Chul
    Chui, Linda
    Wang, Yang
    Shen, Jianzhong
    Jeon, Byeonghwa
    [J]. EMERGING INFECTIOUS DISEASES, 2016, 22 (05) : 802 - 809
  • [39] Toxin gene expression by shiga toxin-producing Escherichia coli:: the role of antibiotics and the bacterial SOS response
    Kimmitt, PT
    Harwood, CR
    Barer, MR
    [J]. EMERGING INFECTIOUS DISEASES, 2000, 6 (05) : 458 - 465
  • [40] Foodborne transmission of sorbitol-fermenting Escherichia coli O157:[H7] via ground beef: an outbreak in northern France, 2011
    King, L. A.
    Loukiadis, E.
    Mariani-Kurkdjian, P.
    Haeghebaert, S.
    Weill, F-X
    Baliere, C.
    Ganet, S.
    Gouali, M.
    Vaillant, V.
    Pihier, N.
    Callon, H.
    Novo, R.
    Gaillot, O.
    Thevenot-Sergentet, D.
    Bingen, E.
    Chaud, P.
    de Valk, H.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (12) : O1136 - O1144